手环与自我导向观察疗法控制结核病:整群随机对照试验研究方案
该研究方案分三阶段:开发可储药并记录服药依从性的手环、创建支持提醒及医患互动的BSDOT智能手机应用、在中国湖南省开展整群随机对照试验。干预组获免费手环和智能手机并由手机指导每日服药,对照组无干预;主要结局为WHO定义的结核治疗结果,次要结局为治疗依从性(漏服少于5%剂量的患者百分比)。
要点
- 干预组获免费手环和智能手机并由手机指导每日服药,对照组无干预。
- 主要结局为WHO定义的结核治疗结果,次要结局为漏服少于5%剂量的患者百分比。
- 用MGLS量表评估自我报告的依从性,并评估结核知识及生活质量。
核心结论
- 作者认为BSDOT将是加强结核病控制与预防的有力手段,尤其针对耐多药结核流行。
- 作者认为这种基于智能手机的新工具可方便地用于卫生保健设施有限且经济资产匮乏的低资源偏远环境。
研究设计与样本
- 研究分三阶段:开发能储药并记录服药依从性的手环、创建支持提醒及医患互动的BSDOT智能手机应用、在中国湖南省开展整群随机对照试验。
- 干预组获免费手环和智能手机并由手机指导每日服药,对照组无干预。
- 采用回归模型探索干预是否改善药物依从性及其他结局指标。
- 方案已获中南大学湘雅公共卫生学院伦理委员会批准(编号XYGW-2016-14),于2016年6月5日在中国临床试验注册中心注册(ID:ChiCTR-IOR-16008424)。
关键数值与推荐
- 主要结局为WHO定义的结核治疗结果:治愈、完成治疗、治疗失败、死亡、失访、未评价或治疗成功。
- 次要结局为治疗依从性,定义为接受结核治疗的患者中漏服少于5%剂量的患者百分比。
- 采用Morisky、Green和Levine依从性量表(MGLS)评估自我报告的依从性,并评估受访者的结核知识和生活质量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Approximately 80% of global tuberculosis (TB) cases occur in low-resource settings, with little opportunity for TB control. We hypothesized that the rapid increase in smartphone users and advances in digital technology would render bracelet-based applications possible; specifically, that bracelet- and self-directed observational therapy (BSDOT) can be used by patients with TB to ensure adherence to TB medication regimens and by basic village physicians to monitor care. This will ultimately allow TB to be controlled in low-resource environments. METHODS AND DESIGN: This study will have three phases: development of a bracelet capable of storing pills and recording adherence to medication regimens; creation of a BSDOT smartphone application capable of supporting reminders to patients and health care interactions between patients and village physicians; and performance of a cluster randomized controlled trial in Hunan Province, China. Patients in the intervention group will receive free bracelets and smartphones, and their daily medication intake will be directed by the smartphones; the control group will receive no intervention. The primary outcome will be the TB treatment result as defined by the World Health Organization (WHO) as follows: Cured, Treatment completed, Treatment failed, Died, Lost to follow-up, Not evaluated, or Treatment success. The secondary outcome will be treatment adherence, defined as the percentage of patients receiving TB treatment who missed fewer than 5% of doses. We will also assess self-reported adherence using the Morisky, Green, and Levine Adherence Scale (MGLS) and evaluate respondents' knowledge about TB and quality of life. A regression model will be used to explore whether the interventions improve drug adherence and other outcome measures. DISCUSSION : This will be a powerful means by which to strengthen TB control and prevent TB, especially multidrug-resistant epidemics of the disease. In addition, our novel smartphone-based tool can be readily adopted for use in low-resource remote environments with limited health care facilities and few economic assets. ETHICS AND DISSEMINATION: The protocol has been approved by the Ethics Committee of Xiangya School of Public Health, Central South University (reference number: XYGW-2016-14). TRIAL REGISTRATION: Chinese Clinical Trial Registry, ID: ChiCTR-IOR-16008424 . Registered on 5 June 2016.
引用
- Huang R, Ren G, Hu J, et al. Bracelet- and self-directed observational therapy for control of tuberculosis: study protocol for a cluster randomized controlled trial. Trials. 2017. PMID: 28673323. doi:10.1186/s13063-017-1996-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。